Sonoma Pharmaceuticals (SNOA) Equity Average (2016 - 2022)
Sonoma Pharmaceuticals (SNOA) has 2 years of Equity Average data on record, last reported at $1.3 million in Q4 2012.
- For Q4 2012, Equity Average rose 9629.63% year-over-year to $1.3 million; the TTM value through Dec 2012 reached $1.3 million, up 9629.63%, while the annual FY2012 figure was $416500.0, N/A changed from the prior year.
- Equity Average reached $1.3 million in Q4 2012 per SNOA's latest filing, up from -$79500.0 in the prior quarter.
- Across five years, Equity Average topped out at $1.3 million in Q4 2012 and bottomed at -$352500.0 in Q1 2012.